Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
VBI Vaccines (NASDAQ: VBIV) has seen an enormous jump in its share price ahead of the US market open on Thursday after closing Wednesday's trading session down almost 2%…
The jump is a result of Raymond James (NYSE: RFJ) upgrading the stock to a “Strong Buy”, but the upgrade alone is not the primary reason's why VBIV's shares have surged…
Raymond James stated that following its first look at VBI's COVID-19 vaccine data, they believe it could be the best vaccine of them all, which includes all of the first movers and Operation Warp Speed members.
That's a big statement!
VBIV stock price…
The news has sent VBI Vaccine's stock price soaring. It is currently trading at $4.27, up 33.02% from yesterday's close of $3.21, at the time of this publication.
Raymond James commented that “We have no idea why the stock wasn't up. We think it will be once the Street looks at the data (here) and concludes what we have concluded, given the analysis is actually quite straightforward.”
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .